Mycosis fungoides and variants
MONDO:0015821Mycosis fungoides (MF) and its variants represent the most common forms of cutaneous T-cell lymphomas. The term MF is restricted to the classical form characterized by the slow progression of patches, plaques and tumors, and to variants with a similar indolent course.
3197 clinical trials for this condition and its sub-types, 4 tagged with Mycosis fungoides and variants itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Mycosis fungoides and variants
-
Mycosis fungoides 82 trials
-
Mycosis fungoides variant 1 trial · 3 incl. sub-types
3 sub-types
- Folliculotropic mycosis fungoides 3 trials
- Granulomatous slack skin disease 1 trial
- Localized pagetoid reticulosis 0 trials
-
New combo therapy hopes to tackle rare skin cancer
Disease control Recruiting nowThis phase II trial tests whether combining a targeted antibody drug (mogamulizumab) with a procedure that treats white blood cells with light (extracorporeal photopheresis) can better control erythrodermic cutaneous T-cell lymphoma, a rare skin cancer. About 34 adults with advan…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Rash or remission? new study aims to decode drug side effect in rare skin cancers
Knowledge-focused Recruiting nowThis study tracks 100 adults with mycosis fungoides or Sézary syndrome who are starting mogamulizumab, a standard treatment. The drug often causes a rash that can look like the cancer itself. Researchers want to help doctors tell the difference so they don't stop a working drug t…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC